Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide

Molecular Pharmacology

Volumn 61, Issue 6, 2002, Pages 1435-1443

  Tokita, Kenji ^a   Hocart, Simon J ^b   Coy, David H ^b   Jensen, Robert T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BOMBESIN; GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR; ISOLEUCINE; NEUROMEDIN B; PHENYLALANINE; RECEPTOR; UNCLASSIFIED DRUG;

AGONIST; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHIMERA; CONTROLLED STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR AFFINITY; RECEPTOR UPREGULATION;

3T3 CELLS; ALANINE; AMINO ACID SEQUENCE; ANIMALS; GASTRIN-RELEASING PEPTIDE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PHENYLALANINE; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RADIOLIGAND ASSAY; RECEPTORS, BOMBESIN; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

EID: 0036262646     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.61.6.1435     Document Type: Article

References (43)

1. Identification of four amino acids in the gastrin-releasing peptide C receptor that are required for high affinity agonist binding
2. Interaction of colocalized neuropeptides: Functional significance in the circadian timing system
3. 1 receptor for high affinity binding of peptide antagonists
4. Expression and characterization of cloned human bombesin receptors
5. Mutagenesis and ligand modification studies on galanin binding to its GTP-binding-protein-coupled receptor GalR1
6. Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors
7. Bombesin: Central nervous system actions to affect the autonomic nervous system
8. Gastrin-releasing peptide
9. Aromatic-aromatic interaction: A mechanism of protein structure stabilization
10. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells
11. Bombesin receptor antagonists
12. Stimulation of natural killer and antibody-dependent cellular cytotoxicity activities in mouse leukocytes by bombesin, gastrin-releasing peptide and neuromedin C: Involvement of cyclic AMP, inositol 1,4,5-trisphosphate and protein kinase C
13. Cation-pi interactions in chemistry and biology: A new view of benzene, Phe, Tyr, and Trp
14. Discovery, isolation and characterization of bombesin-like peptides
15. The fifth transmembrane segment of the neuromedin B receptor is critical for high affinity neuromedin B binding
16. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure
17. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor
18. The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides
19. Cation-pi interactions in structural biology
20. Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors
21. Progress in the development of potent bombesin receptor antagonists
22. Differential structural requirements for specific binding ofnonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan
23. The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands
24. Mammalian bombesin receptors
25. Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity
26. Distinct distributions of bombesin receptor subtypes in the rat central nervous system
27. The sixth transmembrane domains of the human B1 and B2 bradykinin receptors are structurally compatible and involved in discriminating between subtype-selective agonists
28. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes
29. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates it has a unique pharmacology compared to other mammalian bombesin receptors
30. Bombesin: Potential integrative peptide for feeding and satiety
31. Cation-pi interactions in aromatics of biological and medicinal interest: Electrostatic potential surfaces as a useful qualitative guide
32. Delineation of a region in the B2 bradykinin receptor that is essential for high-affinity agonist binding
33. Neuroniedin B
34. Crystal structure of rhodopsin: A G protein-coupled receptor
35. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes
36. Bombesin-induction of cell proliferation in 3T3 cells. Specific receptors and early signaling events
37. Aromatic-aromatic interactions and protein stability. Investigation by double-mutant cycles
38. Role of the extracellular domains of the cholecystokinin receptor in agonist binding
39. A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin
40. Anti-bombesin monoclonal antibodies modulate fetal mouse lung growth and maturation in utero and in organ cultures
41. International symposium on bombesin-like peptides in health and disease
42. Tyrosine 220 in the fifth transmembrane domain of the neuromedin B receptor is critical for the high selectivity of the peptoid antagonist PD168368
43. Bombesin and C-terminal tetrade-capeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells